Citation data

CrossRef

Works that cite this article, indexed by Crossref.

50 resultsUpdated October 25, 2026
1

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

Journal of Clinical Virology 113 (2019)

Heidar Sharafi; Hossein Poustchi; Fatemeh Azimian; Babak Tamadoni; Rashid Ramezani; Mohamad Mehdi Gouya; Mahdi Sheikh; Farnaz Hashemi; Mehrzad Tashakorian; Ramin Alasvand; Seyed Moayed Alavian; Shahin Merat

2

Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis

Archives of Clinical Infectious Diseases In Press(In Press) (2019)

Mohammad Ehsan Bayatpoor; Mohammad Hossein Khosravi; Heidar Sharafi; Mohammad Saeid Rezaee-Zavareh; Bita Behnava; Seyed Moayed Alavian

3

Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran

Infection, Genetics and Evolution 75 (2019)

Lize Cuypers; Marijn Thijssen; Arash Shakibzadeh; Ward Deboutte; Jamal Sarvari; Farzaneh Sabahi; Mehrdad Ravanshad; Mahmoud Reza Pourkarim

4

Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

Hepatitis Monthly 17(6) (2017)

Heidar Sharafi; Mehri Nikbin; Seyed Hoda Alavian; Bita Behnava; Seyed Moayed Alavian

5

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

Annals of Hepatology 16(2) (2017)

Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Bita Behnava; Seyed Moayed Alavian; Mohammad Gholami-Fesharaki; Heidar Sharafi

6

Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

Hepatitis Monthly 16(12) (2016)

Khashayar Hesamizadeh; Seyed Moayed Alavian; Azar Najafi Tireh Shabankareh; Heidar Sharafi

8

Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C

Toxin Reviews 38(3) (2019)

Nasim Habibi; Mohsen Nassiri-Toosi; Heidar Sharafi; Seyed Moayed Alavian; Masoomeh Shams-Ghahfarokhi; Mehdi Razzaghi-Abyaneh

9

Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C

PLOS ONE 16(4) (2021)

Hala Rady Ahmed; Nancy G. F. M. Waly; Rehab Mahmoud Abd El-Baky; Ramadan Yahia; Helal F. Hetta; Amr M. Elsayed; Reham Ali Ibrahem; Philippe Gallay

10

Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients

IJID Regions 18 (2026)

Aristide Mounchili-Njifon; Abdou Fatawou Modiyinji; Pretty Rosereine Mbouyap; Chavely Gwladys Monamele; Moise Henri Moumbeket-Yifomnjou; Philipe Herman Njitoyap Mfombouot; Gisele Liliane Machuetum; Pascal Ibrahim Toueyem; Simon Frederic Lissock; Paul Alain Tagnouokam-Ngoupo; Jean Paul Assam Assam; Richard Njouom

11

Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection

Shiraz E-Medical Journal 23(9) (2022)

Najmeh Rokhtabnak; Mohammad Reza Ataollahi; Morvarid Asadipour; Mohammad Ali-Hassanzadeh; Pooria Fazeli; Soolmaz Khansalar; Esmaeel Ghani; Kurosh Kalantar

12

Lurking epidemic of hepatitis C virus infection in Iran: A call to action

World Journal of Hepatology 9(24) (2017)

Reza Taherkhani; Fatemeh Farshadpour

13

Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

Journal of Clinical Virology Plus 4(3) (2024)

Marcarious M. Tantuoyir; Muhammed Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad

14

Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients

International Journal of Peptide Research and Therapeutics 26(4) (2020)

Tayebeh Hashempour; Behzad Dehghani; Zahra Mousavi; Maryam Yahaghi; Zahra Hasanshahi; Javad Moayedi; Tahereh Akbari; Mohammad Ali Davarpanah

15

Assessing the Quality of Clinical Practice Guidelines in the Middle East and North Africa (MENA) Region: A Systematic Review

Journal of Multidisciplinary Healthcare Volume 14 (2021)

Saja H Almazrou; Layan A Alsubki; Norah A Alsaigh; Wadha H Aldhubaib; Sharifah M Ghazwani

16

First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients

BMC Gastroenterology 21(1) (2021)

Zahra Hasanshahi; Ava Hashempour; Farzane Ghasabi; Javad Moayedi; Zahra Musavi; Behzad Dehghani; Heidar Sharafi; Hassan Joulaei

17

Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

Archives of Clinical Infectious Diseases In Press(In Press) (2018)

Soheila Khosravi; Heidar Sharafi; Esmaeil Sanei Moghadam; Fariba Heidari; Mahmod Naibzadeh; Seyed Moayed Alavian

18

Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

Iranian Red Crescent Medical Journal 19(5) (2017)

Seyyed Mohammad Miri; Heidar Sharafi; Shima Salimi; Farah Bokharaei-Salim; Bita Behnava; Maryam Keshvari; Pegah Karimi Elizee; Hosein Keyvani; Seyed Moayed Alavian

20

Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

Hepatitis Monthly In Press(In Press) (2018)

Saman Mohazzab-Torabi; Fardin Dolatimehr; Heidar Sharafi; Mahdi Safi-Abadi; Mohammad Saeid Rezaee-Zavareh; Ehsan Bayatpour; Hamidreza Karimi-Sari; Seyed Moayed Alavian

21

Awareness Campaign in (bio)Medical Students in Iran: a model for increasing the knowledge regarding hepatitis B and C

Clinical Microbiology and Infection 23(6) (2017)

H. Karimi-Sari; M.E. Bayatpoor; S.M. Alavian

22

An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study

International Journal of Drug Policy 102 (2022)

Ali Mirzazadeh; Samira Hosseini-Hooshyar; Armita Shahesmaeili; Heidar Sharafi; Mohammad Shafiei; Jasem Zarei; Ghazal Mousavian; Fatemeh Tavakoli; Nima Ghalekhani; Mostafa Shokoohi; Mehrdad Khezri; Soheil Mehmandoost; Mohammad Reza Shojaei; Mohammad Karamouzian; Alya Briceno; Meghan D. Morris; Seyed Moayed Alavian; Ali-Akbar Haghdoost; Hamid Sharifi; Kimberly A. Page

23

The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3

Hepatitis Monthly 17(1) (2016)

Shahin Merat; Amir Houshang Sharifi; Arghavan Haj-Sheykholeslami; Hossein Poustchi; Babak Fattahi; Alireza Nateghi-Baygi; Seyed Moayed Alavian; Reza Malekzadeh

24

Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

Microbial Drug Resistance 25(7) (2019)

Heidar Sharafi; Saman Ghalamkari; Alireza Hassanshahi; Seyed Moayed Alavian

25

Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis

Hepatitis Monthly 17(6) (2017)

Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Heidar Sharafi; Seyed Moayed Alavian

26

The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis

Archives of Virology 163(5) (2018)

Masoud Behzadifar; Hassan Abolghasem Gorji; Nicola Luigi Bragazzi

27

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

World Journal of Hepatology 10(9) (2018)

Heidar Sharafi; Seyed Moayed Alavian

28

Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis

Hepatitis Monthly 17(2) (2017)

Babak Mirminachi; Zahra Mohammadi; Shahin Merat; Afarin Neishabouri; Amir Houshang Sharifi; Seyed Hoda Alavian; Hosein Poustchi; Reza Malekzadeh

30

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

Virology Journal 18(1) (2021)

Heidar Sharafi; Bita Behnava; Alireza Azizi-saraji; Ali Namvar; Ali Anvar; Shima Salimi; Seyed Moayed Alavian

31

Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

Hepatitis Monthly 17(11) (2017)

Seyed Moayed Alavian; Heidar Sharafi

32

Prevalence of Occult HCV Infection in Hemodialysis and Kidney-Transplanted Patients: A Systematic Review

Future Virology 12(5) (2017)

Fardin Dolatimehr; Mohammad Hossein Khosravi; Mohammad Saeid Rezaee-Zavareh; Seyed Moayed Alavian

33

The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy

Hepatitis Monthly 17(4) (2017)

Seyyed Mohammad Miri; Heidar Sharafi; Ali Pouryasin; Bita Behnava; Maryam Keshvari; Shima Salimi; Pegah Karimi Elizee; Seyed Moayed Alavian

34

Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients

Current HIV Research 19(5) (2021)

Kazem Baesi; Ali Akbar Velayati; Masoumeh Farrokh Ashtiani; Kamal Fakhredini; Mohammad Banifazl; Mona Sadat Larijani; Parya Basimi; Amitis Ramezani

35

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

DARU Journal of Pharmaceutical Sciences 25(1) (2017)

Fardin Dolatimehr; Hamidreza Karimi-Sari; Mohammad Saeid Rezaee-Zavareh; Seyed Moayed Alavian; Bita Behnava; Mohammad Gholami-Fesharaki; Heidar Sharafi

36

Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

Hepatitis Monthly 17(6) (2017)

Masood Ziaee; Morteza Hajihosseini

37

Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation

Alimentary Pharmacology & Therapeutics 46(1) (2017)

M. S. Rezaee‐Zavareh; S. M. Alavian

38

Research progress on the direct antiviral drugs for hepatitis C virus

BioScience Trends 11(1) (2017)

Jianjun Gao; Chuanxia Ju

39

Global elimination of hepatitis C virus infection: Progresses and the remaining challenges

World Journal of Hepatology 9(33) (2017)

Reza Taherkhani; Fatemeh Farshadpour

40

Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies

Journal of Virus Eradication 6(3) (2020)

Meisam Moghimbeygi; Seyed Moayed Alavian

42

Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

Iranian Red Crescent Medical Journal 19(12) (2017)

Hossein Ghaderi-Zefrehi; Heidar Sharafi; Farzin Sadeghi; Mohammad Gholami-Fesharaki; Alireza Farasat; Fatemeh Jahanpeyma; Seyed Moayed Alavian

43

Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia

Journal of Medical Virology 91(3) (2019)

Arezoo Khosravi; Hamidreza Karimi‐Sari; Mahdi Abedi‐Andani; Bita Behnava; Ali Namvar; Ali Anvar; Seyed Moayed Alavian

44

Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population

Clinics and Research in Hepatology and Gastroenterology 43(5) (2019)

Amitis Ramezani; Kazem Baesi; Mohammad Banifazl; Minoo Mohraz; Farzin Khorvash; Majid Yaran; Payam Tabarsi; Amir hosein Dalirrooyfard; Fatemeh Motevalli; Anahita Bavand; Arezoo Aghakhani

45

Chronic Hemodialysis Patients; Special Group for Hepatitis C Elimination Programs in Iran

Nephro-Urology Monthly 9(6) (2017)

Hamidreza Karimi-Sari; Seyed Moayed Alavian

46

Update on Transmission Modes of Hepatitis C Virus Among Volunteer Iranian Blood Donors: Analysis of a Matched Case-Control Study by Penalized Conditional Logistic Regression

Hepatitis Monthly In Press(In Press) (2018)

Fahimeh Ranjbar Kermani; Kamran Mousavi Hosseini; Sedigheh Amini Kafi-abad; Mahtab Maghsudlu; Zohreh Sharifi; Mohammad Ali Mansournia; Seyed Moayed Alavian

47

SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

Clinical Infectious Diseases 70(10) (2020)

Shahin Merat; Shahin Merat; Amir-Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour-Ghanaei; Mohammad-Reza Fattahi; Lida Ahmadi; Mohammad-Hossein Somi; Hamid Kalantari; Mohammad-Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyedhamid Moosavy; Masood Ziaee; Mohammad-Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani-Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Ali-Akbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Fakheri; Mohammad Minakari; Hossein Sardarian; Adel Fallah Ghajary; Mojtaba Fattahi-Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh-Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Hill; Reza Malekzadeh

48

Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation

Journal of Clinical Virology 124 (2020)

Ashly E. Jordan; David C. Perlman; Charles M. Cleland; Katarzyna Wyka; Bruce R. Schackman; Denis Nash

49

Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents

Clinical Microbiology and Infection 26(8) (2020)

H. Karimi-Sari; M.A. Hosseini; N. Nikjoo; M.S. Bagheri Baghdasht; S.M. Alavian